Preclinical Inflammation Pharmacology Services

Inflammatory and autoimmune diseases can cause serious medical conditions in many areas of the body.

Companies that offer Preclinical Inflammation Pharmacology Services provide models that can be used to help with drug discovery and development. Since many inflammatory indications share mechanisms of action – service provides have the ability to bundle lead optimization with cell-based screening and in vivo pharmacology studies. The combination of these services, tests and analyses can offer quick cycle times and enable efficient switching between indications of relevance.